Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Gains from Investment Securities: 2011-2025

Historic Gains from Investment Securities for Prestige Consumer Healthcare (PBH) over the last 15 years, with Mar 2025 value amounting to $5.8 million.

  • Prestige Consumer Healthcare's Gains from Investment Securities rose 422.58% to $162,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $10.0 million, marking a year-over-year decrease of 11.52%. This contributed to the annual value of $5.8 million for FY2025, which is 5.88% up from last year.
  • Prestige Consumer Healthcare's Gains from Investment Securities amounted to $5.8 million in FY2025, which was up 5.88% from $5.5 million recorded in FY2024.
  • Prestige Consumer Healthcare's 5-year Gains from Investment Securities high stood at $7.9 million for FY2021, and its period low was $2.9 million during FY2022.
  • Over the past 3 years, Prestige Consumer Healthcare's median Gains from Investment Securities value was $5.5 million (recorded in 2024), while the average stood at $5.6 million.
  • As far as peak fluctuations go, Prestige Consumer Healthcare's Gains from Investment Securities spiked by 706.37% in 2021, and later crashed by 62.87% in 2022.
  • Over the past 5 years, Prestige Consumer Healthcare's Gains from Investment Securities (Yearly) stood at $7.9 million in 2021, then slumped by 62.87% to $2.9 million in 2022, then surged by 87.45% to $5.5 million in 2023, then rose by 0.77% to $5.5 million in 2024, then grew by 5.88% to $5.8 million in 2025.